Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma

Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma

Abstract Hepatocellular carcinoma (HCC) imposes a huge global burden, arising from various etiological factors such as hepatitis virus infection and metabolic syndrome. While prophylactic vaccination and antiviral treatment have decreased the incidence of viral HCC, the growing prevalence of metabol...

Full description

Bibliographic Details
Main Authors: Kohei Yagi, Shu Shimada, Yoshimitsu Akiyama, Megumi Hatano, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Shuichi Watanabe, Keiichi Akahoshi, Hiroaki Ono, Minoru Tanabe, Shinji Tanaka
Format: Article
Language:English
Published: Nature Portfolio 2023-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-36660-w

Internet

https://doi.org/10.1038/s41598-023-36660-w

Similar Items